Total Payments
$117,905
2024 Payments
$26,946
Companies
36
Transactions
654
Medicare Patients
4,308
Medicare Billing
$514,527
Payment Breakdown by Category
Other$74,513 (63.2%)
Consulting$15,903 (13.5%)
Travel$14,803 (12.6%)
Food & Beverage$12,571 (10.7%)
Education$114.17 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,213 | 25 | 62.9% |
| Consulting Fee | $15,903 | 4 | 13.5% |
| Travel and Lodging | $14,803 | 38 | 12.6% |
| Food and Beverage | $12,571 | 582 | 10.7% |
| Grant | $300.00 | 2 | 0.3% |
| Education | $114.17 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $93,472 | 276 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $7,297 | 43 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $5,585 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $4,914 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,552 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $891.01 | 78 | $0 (2024) |
| PFIZER INC. | $447.56 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $370.60 | 25 | $0 (2023) |
| Gilead Sciences, Inc. | $333.50 | 30 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $332.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,946 | 68 | ABBVIE INC. ($26,677) |
| 2023 | $47,010 | 82 | ABBVIE INC. ($41,376) |
| 2022 | $23,402 | 57 | ABBVIE INC. ($23,260) |
| 2021 | $5,613 | 20 | Ferring Pharmaceuticals Inc. ($5,358) |
| 2020 | $502.54 | 31 | AbbVie Inc. ($126.47) |
| 2019 | $2,846 | 164 | AbbVie, Inc. ($483.57) |
| 2018 | $9,606 | 128 | Takeda Pharmaceuticals U.S.A., Inc. ($6,880) |
| 2017 | $1,980 | 104 | AbbVie, Inc. ($706.62) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $115.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: VIROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.05 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $700.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $38.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $38.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $34.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $34.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $36.34 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $117.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: VIROLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 955 | 1,024 | $334,047 | $123,121 |
| 2022 | 14 | 1,099 | 1,200 | $344,806 | $131,151 |
| 2021 | 15 | 1,129 | 1,215 | $352,467 | $130,969 |
| 2020 | 14 | 1,125 | 1,284 | $376,363 | $129,286 |
Total Patients
4,308
Total Services
4,723
Medicare Billing
$514,527
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 113 | 115 | $62,324 | $21,380 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 205 | $46,328 | $19,428 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 122 | $36,966 | $16,416 | 44.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $38,304 | $13,643 | 35.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 153 | 155 | $45,880 | $12,226 | 26.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 76 | 76 | $32,452 | $10,838 | 33.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 45 | 45 | $17,640 | $8,321 | 47.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $18,759 | $6,516 | 34.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 34 | 35 | $13,869 | $6,478 | 46.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $9,030 | $3,335 | 36.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $6,681 | $2,276 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 38 | $5,814 | $2,264 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 270 | $61,020 | $27,279 | 44.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 78 | 78 | $42,237 | $15,170 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 115 | 115 | $39,330 | $14,478 | 36.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 86 | 86 | $36,745 | $12,725 | 34.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 154 | 156 | $46,776 | $11,537 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 78 | $23,634 | $11,232 | 47.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 50 | 50 | $19,600 | $9,559 | 48.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 125 | 125 | $28,250 | $9,400 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 95 | $14,535 | $6,616 | 45.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $11,554 | $4,350 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $9,030 | $3,716 | 41.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $6,681 | $3,261 | 48.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 61 | 63 | $2,709 | $1,145 | 42.3% |
About Dr. Ronald Hsu, MD
Dr. Ronald Hsu, MD is a Gastroenterology healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700912318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Hsu, MD has received a total of $117,905 in payments from pharmaceutical and medical device companies, with $26,946 received in 2024. These payments were reported across 654 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,213).
As a Medicare-enrolled provider, Hsu has provided services to 4,308 Medicare beneficiaries, totaling 4,723 services with total Medicare billing of $514,527. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Roseville, CA
- Active Since 02/26/2007
- Last Updated 06/20/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1700912318
Products in Payments
- RINVOQ (Biological) $53,384
- SKYRIZI (Biological) $34,224
- Entyvio (Biological) $6,981
- CIMZIA (Drug) $5,358
- HUMIRA (Biological) $3,433
- XIFAXAN (Drug) $1,327
- Humira (Biological) $1,151
- STELARA (Biological) $962.01
- XELJANZ (Drug) $394.62
- BREATHTEK (Device) $332.00
- Mavyret (Drug) $330.43
- LINZESS (Drug) $270.67
- DIFICID (Drug) $265.84
- Sucraid (Drug) $265.46
- DUPIXENT (Biological) $239.00
- MAVYRET (Drug) $196.70
- XIFAXANIBSD (Drug) $154.19
- SUPREP (Drug) $150.73
- Trulance (Drug) $139.19
- REBYOTA (Biological) $138.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Roseville
Dr. Anand Madan, M.d, M.D
Gastroenterology — Payments: $26,461
Gastroenterology $26,461
Randell Vallero, Md, MD
Gastroenterology — Payments: $20,029
Gastroenterology $20,029
Jasbir Rangi, Md, MD
Gastroenterology — Payments: $17,959
Gastroenterology $17,959
Rakesh Parikh, Md, MD
Gastroenterology — Payments: $13,384
Gastroenterology $13,384
John Canio, M.d, M.D
Gastroenterology — Payments: $13,126
Gastroenterology $13,126
Dr. Rahul Dhillon, M.d, M.D
Gastroenterology — Payments: $4,456
Gastroenterology $4,456